These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18307245)

  • 21. [Dysarthria across Parkinson's disease progression. Natural history of its components: dysphonia, dysprosody and dysarthria].
    Pinto S; Ghio A; Teston B; Viallet F
    Rev Neurol (Paris); 2010 Oct; 166(10):800-10. PubMed ID: 20800250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subjective emotional experience at different stages of Parkinson's disease.
    Vicente S; Péron J; Biseul I; Ory S; Philippot P; Drapier S; Drapier D; Vérin M
    J Neurol Sci; 2011 Nov; 310(1-2):241-7. PubMed ID: 21741663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vowel articulation in Parkinson's disease.
    Skodda S; Visser W; Schlegel U
    J Voice; 2011 Jul; 25(4):467-72. PubMed ID: 20434876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Startling facts about emotion in Parkinson's disease: blunted reactivity to aversive stimuli.
    Bowers D; Miller K; Mikos A; Kirsch-Darrow L; Springer U; Fernandez H; Foote K; Okun M
    Brain; 2006 Dec; 129(Pt 12):3356-65. PubMed ID: 17095520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequential changes in motor speech across a levodopa cycle in advanced Parkinson's disease.
    De Letter M; Van Borsel J; Boon P; De Bodt M; Dhooge I; Santens P
    Int J Speech Lang Pathol; 2010 Oct; 12(5):405-13. PubMed ID: 20602581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acoustic analysis of parkinsonian speech I: speech characteristics and L-Dopa therapy.
    Goberman AM; Coelho C
    NeuroRehabilitation; 2002; 17(3):237-46. PubMed ID: 12237505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of Parkinson's disease on vocal-prosodic communication from the perspective of listeners.
    Pell MD; Cheang HS; Leonard CL
    Brain Lang; 2006 May; 97(2):123-34. PubMed ID: 16226803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abnormal emotional word ratings in Parkinson's disease.
    Hillier A; Beversdorf DQ; Raymer AM; Williamson DJ; Heilman KM
    Neurocase; 2007 Apr; 13(2):81-5. PubMed ID: 17566939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative analysis of speech impairment and upper limb motor dysfunction in Parkinson's disease.
    Rusz J; Tykalová T; Krupička R; Zárubová K; Novotný M; Jech R; Szabó Z; Růžička E
    J Neural Transm (Vienna); 2017 Apr; 124(4):463-470. PubMed ID: 27933492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gender-related patterns of dysprosody in Parkinson disease and correlation between speech variables and motor symptoms.
    Skodda S; Visser W; Schlegel U
    J Voice; 2011 Jan; 25(1):76-82. PubMed ID: 20381998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Speech disorders in Parkinson patients].
    Kerschan K; Pankl W; Auff E
    Wien Klin Wochenschr; 1998 Apr; 110(8):279-86. PubMed ID: 9615959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impaired perception of vocal emotions in Parkinson's disease: influence of speech time processing and executive functioning.
    Breitenstein C; Van Lancker D; Daum I; Waters CH
    Brain Cogn; 2001 Mar; 45(2):277-314. PubMed ID: 11237372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Motor instability in parkinsonian speech intensity.
    Ho AK; Iansek R; Bradshaw JL
    Neuropsychiatry Neuropsychol Behav Neurol; 2001; 14(2):109-16. PubMed ID: 11417664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perceptual characteristics of Parkinsonian speech: a comparison of the pharmacological effects of levodopa across speech and non-speech motor systems.
    Plowman-Prine EK; Okun MS; Sapienza CM; Shrivastav R; Fernandez HH; Foote KD; Ellis C; Rodriguez AD; Burkhead LM; Rosenbek JC
    NeuroRehabilitation; 2009; 24(2):131-44. PubMed ID: 19339752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spatial emotional akinesia in Parkinson disease.
    Drago V; Foster PS; Skidmore F; Trifiletti D; Heilman KM
    Cogn Behav Neurol; 2008 Jun; 21(2):92-7. PubMed ID: 18541985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Speech dysfunction in early Parkinson's disease.
    Stewart C; Winfield L; Hunt A; Bressman SB; Fahn S; Blitzer A; Brin MF
    Mov Disord; 1995 Sep; 10(5):562-5. PubMed ID: 8552106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acoustic analysis of prosody in females with Parkinson's disease: effect of L-dopa].
    Azevedo LL; Cardoso F; Reis C
    Arq Neuropsiquiatr; 2003 Dec; 61(4):995-8. PubMed ID: 14762605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bradykinetic utterances and monopitch speech in patients with Parkinson's disease].
    Kawada N; Miyazaki M; Matsuyama M; Murai K; Nakatani K
    Rinsho Shinkeigaku; 2004 Oct; 44(10):703-6. PubMed ID: 15568489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Excitability of the lower-limb area of the motor cortex in Parkinson's disease.
    Vacherot F; Attarian S; Eusebio A; Azulay JP
    Neurophysiol Clin; 2010 Aug; 40(4):201-8. PubMed ID: 20674816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Levodopa-sensitive, dynamic changes in effective connectivity during simultaneous movements in Parkinson's disease.
    Palmer SJ; Eigenraam L; Hoque T; McCaig RG; Troiano A; McKeown MJ
    Neuroscience; 2009 Jan; 158(2):693-704. PubMed ID: 18722512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.